Cross-country measures for monitoring epilepsy care

Epilepsia

Volumn 48, Issue 5, 2007, Pages 990-1001

  Begley, Charles E ^a,k   Baker, Gus A ^b   Beghi, Ettore ^c   Butler, James ^d   Chisholm, Daniel ^e   Langfitt, John T ^f   Levy, Pierre ^g   Pachlatko, Christoph ^h   Wiebe, Samuel ⁱ   Donaldson, Karen Lee ^j  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^d STELLENBOSCH UNIVERSITY   (South Africa)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

^f UNIVERSITY OF ROCHESTER   (United States)

^g UNIVERSITÉ PARIS DAUPHINE   (France)

^h SWISS EPILEPSY CENTER   (Switzerland)

ⁱ FOOTHILLS HOSPITAL   (Canada)

^j Epilepsy Action   (United Kingdom)

^k UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

more..

Author keywords

Evaluation; Healthcare; International; Survey

Indexed keywords

ARTICLE; DEVELOPING COUNTRY; DISABILITY; EPILEPSY; FEASIBILITY STUDY; HEALTH CARE AVAILABILITY; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH SERVICE; MONITORING; PATIENT CARE; PERFORMANCE; PILOT STUDY; PRIORITY JOURNAL; RESOURCE MANAGEMENT; WORLD HEALTH ORGANIZATION;

AFRICA SOUTH OF THE SAHARA; COST OF ILLNESS; CROSS-CULTURAL COMPARISON; DELIVERY OF HEALTH CARE, INTEGRATED; DEVELOPING COUNTRIES; EPILEPSY; GREAT BRITAIN; HEALTH CARE COSTS; HEALTH CARE SURVEYS; HEALTH POLICY; HEALTH SERVICES NEEDS AND DEMAND; HEALTH SERVICES RESEARCH; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PILOT PROJECTS; QUALITY-ADJUSTED LIFE YEARS; WORLD HEALTH ORGANIZATION;

EID: 34248569699     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2007.00981.x     Document Type: Article

References (46)

1. Allotey P, Reidpath D, Kouame A, Cummins R 2003) The DALY, context and the determinants of the severity of disease: an exploratory comparison of paraplegia in Australia and Cameroon. Social Science and Medicine 57 : 949 958.
2. Arnesen T, Kapiriri L 2004). Can the value choices in DALYs influence global priority-setting Health Policy 70 : 137 149.
3. Beghi E, Garattini L, Ricci E, Cornago D, Parazzini F, EPICOS Group 2004) Direct cost of medical management of epilepsy among adults in Italy: a prospective cost-of-illness study (EPICOS). Epilepsia 45 : 171 178.
4. Begley CE, Lairson DR, Reynolds TF, Coan S 2001). Early treatment cost in epilepsy and how it varies with seizure type and frequency. Epilepsy Research 47 : 205 213.
5. Benatar SR 1997) Health care reform in the new South Africa. New England Journal of Medicine 336 : 891 895.
6. Chisholm D 2005) Cost-effectiveness of first-line antiepileptic drug treatments in the developing world: a population-level analysis. Epilepsia 46 : 751 759.
7. Darby C, Valentine N, Murray CJL, de Silva A 2000). WHO: strategy on measuring responsiveness. Geneva, World Health Organization, Evidence and Information for Policy Discussion Paper No. 23.
8. United Nations, Department of Economic and Social Affairs 2003) World population prospects: The 2000 Revision New York: United Nations.
9. De Silva A 2000). A Framework for Measuring Responsiveness. Geneva World Health Organisation, Evidence and Information for Policy Discussion paper No. 32.
10. De Zelicourt M, Buteau L, Fagnani F, Buteau L, Fagnani F, Jallon P 2000) The contributing factors to medical cost of epilepsy: an estimation based on a French prospective cohort study of patients with newly diagnosed epileptic seizures (the CAROLE study). Active Coordination of the Longitudinal Observational Network in Epilepsy. Seizure 9 : 88 95.
11. Fingerhut LA, Cox CS, Warner M 1998) International comparative analysis of injury mortality. Findings from the ICE on injury statistics. International collaborative effort on injury statistics. Advance Data 303 : 1 20.
12. Hauser WA, Kurland LT 1975) The epidemiology of epilepsy in Rochester, Minnesota, 1935 through 1967. Epilepsia 16 : 1 66.
13. Jacoby A, Buck D, Baker G, McNamee P, Graham-Jones S, Chadwick D 1998) Uptake and costs of care for epilepsy: findings from a U.K. regional study. Epilepsia 39 : 776 786.
14. Jallon P, Loiseau P, Loiseau J 2001) Newly diagnosed unprovoked epileptic seizures: presentation at diagnosis in CAROLE study. Epilepsia 42 : 464 475.
15. Kale R 2002) The treatment gap. Epilepsia 43 (suppl.6 31 33.
16. Kwan P, Brodie MJ 2001). Effectiveness of first antiepileptic drug. Epilepsia 42 : 1255 1260.
17. Langfitt JT, Vickrey BG, McDermott M, Messing S, Berg AT, Spencer SS, Sperling MR, Bazil CW, Shinnar S 2006) Validity and responsiveness of generic preference-based HRQOL instruments in chronic epilepsy. Quality of Life Research 15 : 899 914.
18. Leary PM, Riordan G, Schlegel B, Morris S 1999). Childhood secondary (symptomatic) epilepsy, seizure control, and intellectual handicap in a nontropical region of South Africa. Epilepsia 40 : 1110 1113.
19. Leonardi M, Ustun TB 2002) The global burden of epilepsy. Epilepsia 43 (suppl. 6 21 5.
20. MacDonald BK, Cockerell OC, Sander JWAS, Shorvon SD 2000) The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain 123 : 665 676.
21. Mafojane NA, Appleton CC, Krecek RC, Michael LM, Willingham AL III. 2003) The current status of neurocysticercosis in Eastern and Southern Africa. Acta Tropica 87 : 25 33.
22. Malmgren K, Flink R, Guekht AB, Michelucci R, Neville B, Pedersen B, Pinto F, Stephani U, Ozkara C ILAE Commission of European Affairs, Subcommission on European Guidelines (2003). The provision of epilepsy care across Europe. Epilepsia 44 : 727 731.
23. Meinardi H, Scott RA, Reis R, Sander JWAS 2001) On behalf of the ILAE Commission on the Developing World. The treatment gap in epilepsy: the current situation and ways forward. Epilepsia 42 : 136 149.
24. Messori A, Trippoli S, Becagli P, Cincotta M, Labbate MG, Zaccara G 1998) Adjunctive lamotrigine therapy in patients with refractory seizures: a lifetime cost-utility analysis. European Journal of Clinical Pharmacology 53 : 421 427.
25. Moeller J, Sonntag AK 2002) Assessing the performance of health systems - contributions made by the world health organization. Business Briefing: Global Healthcare 3 : 18 21
26. Moran N, Poole K, Bell G, Solomon J, Kendall S, McCarthy M, McCormick D, Nashef L, Johnson A, Sander J, Shorvon S 2000). NHS services for epilepsy from the patients perspective: a survey of primary, secondary and tertiary care access throughout the UK. Seizure 9 : 559 565.
27. Murray CJL 1996). Rethinking DALYs. In Murray CJL, Lopez ED (Eds) The global burden of disease. Harvard School of Public Health, Boston. pp. 1 98.
28. Murray CJL, Evans DB 2003) Health systems performance assessment: goals, framework and overview. In Murray CJL, Evans DB (Eds). Health systems performance assessment; debates, methods and empiricism. WHO, Geneva, Switzerland, 3 19.
29. Murray CJL, Salomon JA, Mathers CD, Lopez, ED 2002) Summary measures of population health: concepts, ethics, measurement and applications. World Health Organization, Geneva.
30. Ndoye NF, Sow AD, Diop AG, Sessouma B, Sene-Diouf F, Boissy L, Wone I, Toure K, Ndiaye M, Ndiaye P, de Boer H, Engel J, Mandlhate C, Meinardi H, Prilipko L, Sander JW 2005) Prevalence of epilepsy its treatment gap and knowledge, attitude and practice of its population in sub-urban Senegal an ILAE/IBE/WHO study. Seizure 14 : 106 111.
31. Nsengiyumva G, Druet-Cabanac M, Nzisabira L, Preux PM, Vergnenegre A 2004). Economic evaluation of epilepsy in Kiremba (Burundi): a case-control study. Epilepsia 45 : 673 677.
32. Phiri IK, Ngowi H, Afonso S, Matenga E, Boa M, Mukaratirwa S, Githigia S, Saimo M, Sikasunge C, Maingi N, Lubega GW, Kassuku A, Michael L, Siziya S, Krecek RC, Noormahomed E, Vilhena M, Dorny P, Willingham AL 3rd. 2003) The emergence of Taenia solium cysticercosis in Eastern and Southern Africa as a serious agricultural problem and public health risk. Acta Tropuc 87 : 13 23.
33. Preti A, Miotto P 2000) Death by homicide in Italy, 1980-1994: age and gender differences among victims. Medicine, Science, and the Law 40 : 233 240.
34. Preux PM, Druet-Cabanac M 2005) Epidemiology and etiology of epilepsy in sub-Saharan Africa. Lancet Neurology 4 : 21 31.
35. Sander JWAS 2003) The epidemiology of epilepsy revisited. Current Opinion in Neurology 16 : 165 170.
36. Shorvon SD, Farmer PJ 1988) Epilepsy in developing countries: a review of epidemiological, sociocultural, and treatment aspects. Epilepsia 29 (suppl. 1 S36 S54.
37. South African Health Review 2005) Available from http://www.hst.org.za/.
38. Stavem K, Bjornaes H, Lossius MI 2001) Properties of the 15D and EQ-5D utility measures in a community sample of people with epilepsy. Epilepsy Research 44 : 179 189.
39. Tellez-Zenteno JF, Pondal-Sordo M, Matijevic S, Wiebe S 2004) National and regional prevalence of self-reported epilepsy in Canada. Epilepsia 45 : 1623 9.
40. Thomson AJ 1993) Neurocysticercosis - experience at the teaching hospitals of the University of Cape Town. South African Medical Journal 83 : 332 334
41. Valentine NB, de Silva A, Murray CJL 2000). Estimating Responsiveness Level and Distribution for 191 Countries: Methods and Results. GPE Discussion Paper Series: No. 22. Geneva, WHO.
42. Valentine NB, de Silva A, Kawabata K, Darby C, Murray CJL, Evans DB 2003). Health system responsiveness; concepts, domains and operationalization. In Murray CJL, Evans DB (Eds) Health systems performance assessment; debates, methods and empiricism. WHO, Geneva, pp. 573 596.
43. Wang WZ, Wu JZ, Wang DS, Dai XY, Yang B, Wang TP, Yuan CL, Scott RA, Prilipko LL, de Boer HM, Sander JW 2003) The prevalence and treatment gap in epilepsy in China. Neurology 60 : 1544 1545.
44. Wiebe S, Matijevic S, Eliasziw M, Derry PA 2002) Clinically important change in quality of life in epilepsy. Journal of Neurology, Neurosurgery, and Psychiatry 73 : 116 120.
45. World Health Organization 2001) World Health Report 2000. WHO, Geneva.
46. World Health Organization/International Bureau of Epilepsy/International League Against Epilepsy 2005). Epilepsy Care in the World 2005. Geneva, Switzerland.